Pupillometry and ¹²³I-DaTSCAN imaging in Parkinson's Disease: A Comparison Study

REFERENCES

• 1Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann NY Acad Sci. 2003;991:1–14.
   PubMed Web of Science ®Google Scholar
• 2Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol. 2006;5:235–45.
   PubMed Web of Science ®Google Scholar
• 3Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and management. Lancet Neurol. 2009;8:464–74.
   PubMed Web of Science ®Google Scholar
• 4Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2003;24:197–211.
   PubMed Web of Science ®Google Scholar
• 5Forno LS. Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol. 1996;55:259–72.
   PubMed Web of Science ®Google Scholar
• 6Scherfler C, Schwarz J, Antonini A, Grosset D, Valldeoriola F, Marek K, Oertel W, Tolosa E, Lees AJ, Poewe W. Role of DAT-SPECT in the diagnostic work up of Parkinsonism. Mov Disord. 2007;9:1229–38.
   Web of Science ®Google Scholar
• 7Suchowersky O, Reich S, Perlmutter J, Zesiewicz T, Gronseth G, Weiner WJ. Practice parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2006;66:968–75.
   PubMed Web of Science ®Google Scholar
• 8Gasser T. Genomic and proteomic biomarkers for Parkinson disease. Neurology. 2009;72 Suppl 2:S27–31.
   Web of Science ®Google Scholar
• 9Marek K, Jennings D. Can we image premotor Parkinson disease? Neurology. 2009;72 Suppl 2:S21–6.
   Web of Science ®Google Scholar
• 10Piccini PP. Dopamine transporter: basic aspects and neuroimaging. Mov Disord. 2003;18 Suppl 7:S3–8.
   PubMed Web of Science ®Google Scholar
• 11Poewe W, Scherfler C. Role of dopamine transporter imaging in investigation of parkinsonian syndromes in routine clinical practice. Mov Disord. 2003;18 Suppl 7: S16–21.
   Web of Science ®Google Scholar
• 12Lowenfeld IE. The pupil: anatomy, physiology and clinical application. Based on cooperative work with Otto Lowenstein, Boston, MA, USA: Butterworth-Heinemann; 1999.
   Google Scholar
• 13Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55: 181–4.
   PubMed Web of Science ®Google Scholar
• 14Fahn S, Elton RL: UPDRS Program Members. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DM, editors. Recent development in Parkinson's disease. Vol. 2. Florham Park, NJ: MacMillan Healthcare Information; 1987. p. 153–63.
   Google Scholar
• 15Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427–42.
   PubMed Web of Science ®Google Scholar
• 16Mathias C. Autonomic diseases: clinical and laboratory evaluation. J Neurol Neurosurg Psychiatry. 2003;74 Suppl III:31–41.
   Google Scholar
• 17Giza E, Fotiou D, Bostantjopoulou S, Katsarou Z, Karlovasitou A. Pupil light reflex in Parkinson's disease: evaluation with pupillometry. Int J Neurosci. 2011;121:37–43.
   PubMed Web of Science ®Google Scholar
• 18Tatsch K, Asenbaum S, Bartenstein P, Catafau A, Halldin C, Pilowsky LS, Pupi A. European Association of Nuclear Medicine. Procedure guidelines for brain neurotransmission SPET using 123I-labelled dopamine transporters ligands. Eur J Nucl Med. 2002;29:30–5.
   Google Scholar
• 19Wilhelm H, Wilhelm B. Clinical applications of pupillography. J Neuro-Ophthalmol. 2003;23:42–9.
   PubMed Web of Science ®Google Scholar
• 20Biousse V, Skibell BC, Watts RL, Loupe DN, Drews-Botsch C, Newman NJ. Ophthalmologic features of Parkinson's disease. Neurology. 2004;62:177–80.
   PubMed Web of Science ®Google Scholar
• 21Frederick JM, Rayborn ME, Laties AM, Lam DM, Hollyfield JG. Dopaminergic neurons in the human retina. J Comp Neurol. 1982;210:65–79.
   PubMed Web of Science ®Google Scholar
• 22Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson's disease. Ophthalmol Vis Sci. 1990;13:296–302.
   Google Scholar
• 23Harris JP. The pupil in Parkinson's disease. J Psychophysiol. 1991;5:251–5.
   Google Scholar
• 24Hori N, Takamori M, Hirayama M, Watanabe H, Nakamura T, Yamashita F, Ito K, Mabuchi N, Sobue G. Pupillary supersensitivity and visual disturbance in Parkinson's disease. Clin Auton Res. 2008;18:20–7.
   PubMed Web of Science ®Google Scholar
• 25Sugiyama T, Utsumi T. Pupillary dynamics in Parkinson's disease. Neuro-Ophthalmol. 1990;10:1–7.
   Web of Science ®Google Scholar
• 26Smith SA. Pupil function: test and disorders. In: Bannister R, Mathias CJ, editors. Autonomic failure. A textbook of clinical disorders of the autonomic nervous system. 3rd ed. Oxford: Oxford University Press; 1992. p. 421–41.
   Google Scholar
• 27Granholm E, Morris S, Galasko D, Shults C, Rogers E, Vukov B. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease. Int J Psychophysiol. 2003;47:95–115.
   PubMed Web of Science ®Google Scholar
• 28Micieli G, Tassorelli C, Martignoni E, Pacchetti C, Bruggi P, Magri M, Nappi G. Disordered pupil reactivity in Parkinson's disease. Clin Auton Res. 1991;1:55–8.
   PubMedGoogle Scholar
• 29Sawada H, Yamakawa K, Yamakado H, Hosokawa R, Ohba M, Miyamoto K, Kawamura T, Shimohama S. Cocaine and phenylephrine eye drop test for Parkinson disease. JAMA. 2005;293:932–4.
   PubMed Web of Science ®Google Scholar
• 30Stergiou V, Fotiou F, Tsiptsios D, Haidich B, Nakou M, Giantselidis C, Karlovasitou A. Pupillometric findings in patients with Parkinson's disease and cognitive disorder. Int J Psychophysiol. 2008;72:97–101.
   PubMed Web of Science ®Google Scholar
• 31Yashamita F, Hirayama M, Nakamura T, Takamori M, Hori N, Uchida K, Hama T, Sobue G. Pupillary autonomic dysfunction in multiple atrophy and Parkinson's disease: an assessment by eye-drop tests. Clin Auton Res. 2010;20:191–7.
   PubMed Web of Science ®Google Scholar
• 32Jain S, Siegle GJ, Gu C, Moore CG, Ivanco LS, Jennings JR, Steinhauer SR, Studenski S, Greenamyre JT. Autonomic insufficiency in pupillary and cardiovascular systems in Parkinson's disease. Parkinsonism Relat Disord. 2011;17:119–22.
   PubMed Web of Science ®Google Scholar
• 33Reimann M, Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schoels L, Reichmann H, Berg D, Ziemssen T. Comprehensive autonomic assessment does not differentiate between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy. J Neural Transm. 2010;117:69–76.
   PubMed Web of Science ®Google Scholar
• 34Schmidt C, Herting B, Prieur S, Junghanns S, Schweitzer K, Globas C, Schoels L, Reichmann H, Berg D, Ziemssen T. Pupil diameter in darkness differentiates progressive supranuclear palsy from other extrapyramidal syndromes. Mov Disord. 2007;22:2123–6.
   PubMed Web of Science ®Google Scholar
• 35Wakabayashi K, Takahashi H. Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol. 1997;38 Suppl 2:2–7.
   PubMed Web of Science ®Google Scholar
• 36Braak H, de Vos A, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett. 2006;396:67–72.
   PubMed Web of Science ®Google Scholar
• 37Hunter S. The rostral mesencephalon in Parkinson's disease and Alzheimer's disease. Acta Neuropathol. 1985;68:53–8.
   PubMed Web of Science ®Google Scholar
• 38Jellinger KA. Post mortem studies in Parkinson's disease—is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl. 1999;56:1–29.
   PubMedGoogle Scholar
• 39Booij J, Speelman JD, Horstink MW, Wolters EC. The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic Parkinsonism from those with other forms of Parkinsonism. Eur J Nucl Med. 2001;28:266–72.
   PubMedGoogle Scholar
• 40Lokkegaard A, Werdelin LM, Friberg L. Clinical impact of diagnostic SPET investigations with a dopamine re-uptake ligand. Eur J Nucl Med. 2002;29:1623–9.
   Google Scholar
• 41Booij J, Tissingh C, Winogrodzka A, Boer GJ, Stoof JC, Wolters EC, van Royen EA. Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur J Nucl Med. 1997;24: 68–71.
   PubMedGoogle Scholar
• 42Booij J, Sokole EB, Stabin MG, Janssen AG, de Bruin K, van Royen EA. Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters. Eur J Nucl Med. 1998;25:24–30.
   PubMedGoogle Scholar
• 43Booij J, Hemelaar J, Speelman JD, de Bruin K, Janssen AG, van Royen EA. One-day protocol for imaging of the nigrostriatal dopaminergic pathway in Parkinson's disease by [123I]FP-CIT SPECT. J Nucl Med. 1999;40:753–61.
   PubMed Web of Science ®Google Scholar
• 44Huang W-S, Lin S-Z, Lin J-C, Wey SP, Ting G, Liu RS. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging. J Nucl Med. 2001;42:1303–8.
   PubMed Web of Science ®Google Scholar
• 45Marek K, Sibyl JP, Zoghbi SS, Zea-Ponce Y, Baldwin RM, Fussell B, Charney DS, van Dyck C, Hoffer PB, Innis RP. [123I] β-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology. 1996;46:231–7.
   PubMed Web of Science ®Google Scholar
• 46Tatsch K, Schwarz J, Mozley PD, Linke R, Pogarell O, Oertel WH, Fieber RS, Hahn K, Kung HF. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography. Eur J Nucl Med. 1997;24:415–21.
   PubMedGoogle Scholar
• 47Tissingh G, Booij J, Bergmans P, Winogrodzka A, Janssen AG, van Royen EA, Stoof JC, Wolters EC. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane SPECT in healthy controls and early-stage, drug-naïve Parkinson's disease. J Nucl Med. 1998;39:1143–8.
   PubMed Web of Science ®Google Scholar